EP3529359
TUMOR INFILTRATING LYMPHOCYTES FOR USE IN THERAPY
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
18.10.2017EP published:
13.12.2023EP application number:
17861792.4
EPO information:
European Patent Register
Max expiry date:
17.10.2037
Title in English:
TUMOR INFILTRATING LYMPHOCYTES FOR USE IN THERAPYLanguage of the patent:
English
Timeline
Today
18.10.2017EP application
13.12.2023EP Publication
Owner
Name:
Regents of the University of MinnesotaAddress:
600 McNamara Alumni Center 200 Oak Street S.E., Minneapolis, MN 55455-2020, US
Name:
Intima Bioscience, Inc.Address:
3 Columbus Circle, New York, New York 10019, US
Name:
The United States of America, as represented by the Secretary, Department of Health and Human ServicesAddress:
Office of Technology Transfer, National Institutes of Health, 6011 Executive Boulevard, Suite 325, MSC 7660,, Bethesda, MD 20892-7660, US
Inventor
Name:
MORIARITY, BrandenAddress:
Shoreview MN 55126-8516, US
Name:
WEBBER, BeauAddress:
Coon Rapids Minnesota 55448, US
Name:
CHOUDHRY, ModassirAddress:
New York New York 10019, US
Name:
ROSENBERG, Steven A.Address:
Potomac Maryland 20854, US
Name:
PALMER, Douglas C.Address:
N. Bethesda MD 20852, US
Name:
RESTIFO, Nicholas P.Address:
Chevy Chase Maryland 20815, US
Priority
Number:
201662409651 PDate:
18.10.2016Country:
US
Number:
201762452244 PDate:
30.1.2017Country:
US
Classification
Categories:
A61K 35/17, A61P 35/02, A61P 35/00, A61P 31/12, C07K 14/715, C07K 14/705, C07K 14/47, C12N 9/22, C12N 15/113, A61P 31/00